Eka.Care Launches New AI-Based Health Monitoring Feature

India’s medical technology sector is witnessing unprecedented growth, driven by robust government policies, rising demand, and thriving exports. Minister of State for Health Anupriya Patel highlighted that the current industry size of USD 14 billion could potentially exceed USD 30 billion by 2030. With 100 per cent FDI allowed through the automatic route, international investments have surged, bolstering the sector’s expansion.

In a landmark judgment, the Supreme Court has struck down domicile-based reservations in postgraduate (PG) medical courses, calling them a breach of the Constitution’s equality clause under Article 14. The three-judge bench emphasised that "we are all domiciles in the territory of India. We are all residents of India."

The U.S. Food and Drug Administration has approved Novo Nordisk’s Ozempic (semaglutide) to reduce the risk of kidney disease progression, kidney failure, and cardiovascular-related death in patients who have both chronic kidney disease (CKD) and type 2 diabetes.